GADD45A and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, our finding that Gadd45a expression correlates with human CML progression emphasizes the notion that Gadd45a can be used as a biomarker in patient samples and provides the framework for further longitudinal studies in order to correlate Gadd45a expression to CML prognosis.